Mode
Text Size
Log in / Sign up

Artificial intelligence and transformer-based architectures are emerging as key tools in breast cancer researchArtificial Intelligence Shows New Paths for Breast Cancer Care

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the emerging role of transformer-based architectures and explainable AI in breast cancer diagnosis and prognosis.

This systematic review and bibliometric analysis provides a task-aware, methodology-centric perspective on the integration of artificial intelligence (AI) in breast cancer research. The scope includes the evolution of AI applications across diagnosis, prognosis, and treatment-response prediction. The authors identify specific technical trends, such as the adoption of explainable AI and hyperparameter optimization practices.

The analysis highlights the role of mammography as a core modality and identifies emerging research hotspots, including transformer-based architectures. The review also maps the datasets, software frameworks, and algorithms currently shaping the field. These findings aim to support the development of reproducible, interpretable, and clinically integrated AI systems.

Because this is a bibliometric analysis and systematic review of existing literature rather than a clinical trial, the results reflect current research trends rather than direct clinical outcomes. The review serves to provide actionable insights for the development of AI tools in clinical settings. The study does not report specific clinical trial data or patient outcomes.

How this fits prior evidence

This systematic review and bibliometric analysis addresses a gap in the technical landscape of breast cancer management by mapping the role of artificial intelligence and transformer-based architectures. While prior coverage has addressed clinical management strategies, such as combined exercise for cancer-related fatigue and nutrition-oriented perioperative nursing for frailty in older women, this review focuses on the technological infrastructure and research trends in diagnosis and prognosis.

A systematic review and bibliometric analysis explored how artificial intelligence, including machine learning and deep learning, is being used in breast cancer care. The study looked at how these technologies are changing the way doctors approach diagnosis, prognosis, and predicting how patients will respond to treatment.

The research identified several key areas of growth. These include the use of explainable AI to help doctors understand machine decisions, the use of transformer-based architectures, and the role of mammography as a primary tool. The study also mapped out the specific datasets and software frameworks that are currently shaping the field.

Because this is a review of existing research and not a clinical trial, the findings do not provide direct medical recommendations. Instead, the study aims to help researchers create more reliable and interpretable AI systems. These systems are intended to eventually be integrated into clinical settings to support healthcare providers in managing breast cancer.

What this means for you:
This review shows how AI tools are evolving to help doctors diagnose and treat breast cancer more accurately.

Common questions

How is artificial intelligence used in breast cancer care?

Artificial intelligence, including machine learning and deep learning, is being used to improve several areas of care. This includes helping doctors with diagnosis, predicting a patient's prognosis, and determining how a patient might respond to specific treatments.

What specific AI technologies are emerging in this field?

The review identified several emerging research areas. These include the use of transformer-based architectures, the adoption of explainable AI to make systems more interpretable, and the use of specific software frameworks and algorithms to shape the field.

Is this AI technology currently replacing doctors?

No, this study is a review of research and not a clinical trial. The goal of the research is to create systems that are interpretable and can be integrated into clinical settings to support healthcare providers, not replace them.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
IntroductionBreast cancer remains a leading cause of cancer incidence and mortality among women worldwide, with ongoing challenges in early detection, accurate diagnosis, prognosis estimation, and treatment-response assessment. Artificial intelligence (AI), including machine learning and deep learning, has rapidly advanced breast cancer research by enabling analysis of high-dimensional imaging, pathological, genomic, and clinical data. However, the rapid expansion of this literature has resulted in substantial fragmentation across clinical tasks, data modalities, algorithmic paradigms, and software ecosystems. This systematic review presents a comprehensive bibliometric analysis of AI-driven breast cancer research published recently.MethodsUsing a multi-database, Scopus and Web of Science, as primary data sources, a systematic bibliometric framework integrating performance analysis, science mapping, and thematic evolution was employed. The analysis is guided by explicit research questions examining: (i) the evolution of AI applications across diagnosis, prognosis, and treatment-response prediction; (ii) the adoption of explainable AI and hyperparameter optimization practices; (iii) the datasets, software frameworks, and algorithms shaping the field; (iv) the role of mammography as a core modality; and (v) emerging research hotspots, including transformer-based architectures.Results and DiscussionUnlike prior bibliometric studies focused mainly on citation metrics, this work adopts a task-aware, methodologycentric perspective, offering actionable insights to support reproducible, interpretable, and clinically integrated AI systems for breast cancer care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.